Katharina Brett

Katharina Brett is a highly experienced professional in the field of haematology and oncology, currently serving as the National Medical Advisor at Jazz Pharmaceuticals since August 2022. Prior to this role, Katharina held positions at AstraZeneca as a Medical Science Liaison in Oncology and at Biotronik Schweiz AG as an Associate Clinical Project Manager, where responsibilities included conducting international clinical studies and authoring essential clinical documentation. Earlier experience includes project management at Vakzine Projekt Management GmbH, as well as a PhD candidacy at Freie Universität Berlin, focusing on molecular biology and virology, with published research in international journals. Katharina has also contributed to professional networks as Chairwoman of YEBN and held an executive role in btS, facilitating connections between academia and the life sciences industry. Educational qualifications include a Diplom in Biologie and a Doctorate in Virology from Humboldt-Universität zu Berlin, along with a high school diploma from Deutsche Schule Moskau.